Your browser doesn't support javascript.
loading
Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy.
Mena, Esther; Rowe, Steven P; Shih, Joanna H; Lindenberg, Liza; Turkbey, Baris; Fourquet, Aloyse; Lin, Frank I; Adler, Stephen; Eclarinal, Philip; McKinney, Yolanda L; Citrin, Deborah E; Dahut, William; Wood, Bradford J; Chang, Richard; Levy, Elliot; Merino, Maria; Gorin, Michael A; Pomper, Martin G; Pinto, Peter A; Eary, Janet F; Choyke, Peter L; Pienta, Kenneth J.
Afiliação
  • Mena E; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; esther.menagonzalez@nih.gov.
  • Rowe SP; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Shih JH; Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Lindenberg L; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Turkbey B; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Fourquet A; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Lin FI; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Adler S; Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Eclarinal P; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • McKinney YL; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Citrin DE; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Dahut W; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Wood BJ; Center of Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Chang R; Center of Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Levy E; Center of Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Merino M; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Gorin MA; James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Pomper MG; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Pinto PA; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and.
  • Eary JF; Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Choyke PL; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Pienta KJ; James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
J Nucl Med ; 63(8): 1184-1190, 2022 08.
Article em En | MEDLINE | ID: mdl-34916246

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article